Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income	$ 61,929	$ 55,924
Adjustments to reconcile net income to net cash flows from operating activities:
Provision for credit losses on accounts receivable	1,552	357
Reserve for product returns	1,111	2,022
Provision for credit losses on notes receivable	749	3,996
Amortization on patents and tooling	357	417
Amortization and depreciation	14,558	14,417
Amortization of debt issuance costs	3,002	1,811
Amortization of operating leases	7,829	5,953
Deferred income taxes	(15,673)	(24,992)
Change in fair value of contingent liability	(290)	44
Stock-based compensation	18,392	22,481
Loss from investments in unconsolidated entities	3,454	23
Changes in operating assets and liabilities (net of business acquisitions):
Accounts receivable	1,574	4,668
Inventory	(1,544)	16,484
Other current and non-current assets	(4,732)	601
Accounts payable and other current liabilities	(39,711)	(30,437)
Deferred revenue	682	3,022
Operating lease liabilities	(6,393)	(6,751)
Other liabilities	(73)	2,776
Cash flows from operating activities	46,773	72,816
Cash flows used in investing activities:
Business acquisition, net of cash acquired	(23,412)	0
Additions to property and equipment	(10,667)	(5,058)
Issuances of notes receivable	(23,500)	(500)
Receipt of payments on notes receivable	49	26
Capitalized software development costs	(758)	(632)
Purchase of investments in unconsolidated entities	(174,700)	(2,950)
Purchases of other intangible assets	0	(45)
Cash flows used in investing activities	(232,988)	(9,159)
Cash flows (used in) / from financing activities:
Proceeds from issuance of convertible senior notes	0	500,000
Payments of debt issuance costs	0	(13,946)
Purchases of capped calls related to convertible senior notes	0	(63,050)
Payments of deferred consideration for acquisitions	(1,741)	(4,569)
Purchases of treasury stock, including transaction costs	(10,167)	(75,000)
Payments of tax withholdings related to vesting of restricted stock units	0	(3,401)
Issuances of common stock from equity-based plans	2,314	6,734
Cash flows (used in) / from financing activities	(9,594)	346,768
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(184)	(133)
Net (decrease) / increase in cash, cash equivalents and restricted cash	(195,993)	410,292
Cash, cash equivalents and restricted cash at beginning of the period	1,229,132	701,079
Cash, cash equivalents and restricted cash at end of the period	1,033,139	1,111,371
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	1,024,862	1,104,539
Restricted cash included in other current assets and other assets	8,277	6,832
Total cash, cash equivalents and restricted cash	$ 1,033,139	$ 1,111,371